Nutrien Ltd. (NYSE:NTR) Shares Bought by Van ECK Associates Corp

Van ECK Associates Corp lifted its stake in Nutrien Ltd. (NYSE:NTRFree Report) by 5.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,480,870 shares of the company’s stock after acquiring an additional 80,382 shares during the period. Van ECK Associates Corp owned 0.30% of Nutrien worth $66,264,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. HHM Wealth Advisors LLC lifted its stake in shares of Nutrien by 331.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock worth $28,000 after acquiring an additional 480 shares during the period. Exchange Traded Concepts LLC lifted its stake in Nutrien by 96.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock valued at $38,000 after purchasing an additional 416 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new stake in Nutrien during the fourth quarter valued at approximately $67,000. Larson Financial Group LLC lifted its stake in Nutrien by 1,370.6% during the third quarter. Larson Financial Group LLC now owns 1,603 shares of the company’s stock valued at $77,000 after purchasing an additional 1,494 shares during the last quarter. Finally, Cromwell Holdings LLC lifted its stake in Nutrien by 113.4% during the third quarter. Cromwell Holdings LLC now owns 1,694 shares of the company’s stock valued at $82,000 after purchasing an additional 900 shares during the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Stock Up 1.6 %

NTR stock opened at $50.72 on Friday. Nutrien Ltd. has a 12-month low of $43.69 and a 12-month high of $60.87. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The company has a market cap of $24.91 billion, a price-to-earnings ratio of 34.04, a PEG ratio of 1.13 and a beta of 0.81. The company has a 50 day moving average of $48.91 and a two-hundred day moving average of $48.12.

Wall Street Analysts Forecast Growth

Several research firms recently commented on NTR. Wells Fargo & Company increased their target price on shares of Nutrien from $52.00 to $53.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 28th. Raymond James raised shares of Nutrien from a “market perform” rating to an “outperform” rating and increased their target price for the company from $58.00 to $60.00 in a research note on Tuesday, December 3rd. JPMorgan Chase & Co. raised shares of Nutrien from an “underweight” rating to a “neutral” rating and increased their target price for the company from $40.00 to $50.00 in a research note on Monday, January 13th. Piper Sandler boosted their price target on shares of Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Finally, UBS Group upped their price target on shares of Nutrien from $51.00 to $53.00 and gave the company a “neutral” rating in a research report on Tuesday, January 28th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $59.00.

View Our Latest Research Report on Nutrien

About Nutrien

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.